imatinib mesylate has been researched along with Pulmonary Fibrosis in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (59.26) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breda, S; Cagnone, M; Calderan, L; Cavagna, L; Codullo, V; Colombo, M; Cova, E; Distler, JHW; Frangipane, V; Giustra, M; Malatesta, M; Meloni, F; Montecucco, C; Morosini, M; Pacini, C; Pandolfi, L; Prosperi, D; Recalde, H | 1 |
| Jimenez, SA; Wermuth, PJ | 1 |
| Andrianifahanana, M; Becker, J; Edens, M; Gupta, SK; Leof, EB; Maidl, E; Rahimi, RA; Repellin, CE; Wilkes, MC; Wittenberger, J; Yin, X | 1 |
| Fancher, KM; Green, MR; Newton, MD | 1 |
| Aono, Y; Azuma, M; Goto, H; Izumi, K; Kawano, H; Kinoshita, K; Kishi, J; Kishi, M; Nishioka, Y; Sato, S; Takezaki, A; Uehara, H; Yokota, Y | 1 |
| Chen, F; Date, H; Ueki, T; Zhang, J | 1 |
| Bandara, G; Cruse, G; Desai, A; Fischer, ER; Gahl, WA; Gochuico, BR; Kirshenbaum, AS; Lee, CC; Leerkes, M; Metcalfe, DD; O'Brien, KJ; Stone, K | 1 |
| Distler, JH; Distler, O; Manger, B; Schett, G; Spriewald, BM | 1 |
| Distler, JH; Distler, O | 1 |
| Beyer, C; Distler, JH; Distler, O | 1 |
| Crow, MK; Gordon, JK; Kirou, KA; Kloiber, S; Lyman, S; Magro, CM; Mehta, M; Mersten, JN; Spiera, RF; Wildman, HF | 1 |
| Kim, JW; Kim, KH; Kim, SC; Kim, TJ; Kim, YK; Kwon, SS; Lee, SH; Lee, SY; Rhee, CK; Yoon, HK | 1 |
| Abeni, C; Bertocchi, P; Prochilo, T; Zaniboni, A | 1 |
| Akata, S; Aoshima, M; Iwaya, K; Kurakawa, E; Miyazawa, K; Nagate, A; Ohyashiki, K; Serizawa, H; Shimamoto, T; Yokoyama, T | 1 |
| Azuma, A | 1 |
| Aono, Y; Inayama, M; Izumi, K; Kishi, J; Nishioka, Y; Sone, S; Uehara, H; Ugai, M | 1 |
| Chaudhary, NI; Park, JE; Schnapp, A | 1 |
| Bando, M; Ohno, S; Sugiyama, Y; Yamasawa, H | 1 |
| Nathan, SD | 1 |
| Eickelberg, O; Günther, A; Markart, P; Seeger, W | 1 |
| Cottin, V | 1 |
| Wollheim, FA | 1 |
| Distler, JH; Distler, O; Gay, RE; Gay, S; Hauser, T; Huber, LC; Jüngel, A; Michel, BA; Schett, G; Schulze-Horsel, U; Zwerina, J | 1 |
| Chaudhary, NI; Hilberg, F; Müller-Quernheim, J; Park, JE; Prasse, A; Roth, GJ; Schnapp, A; Zissel, G | 1 |
| Li, L; Li, YQ | 1 |
| Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H | 1 |
| Gao, F; Kinnula, VL; Myllärniemi, M; Oury, TD; Vuorinen, K | 1 |
6 review(s) available for imatinib mesylate and Pulmonary Fibrosis
| Article | Year |
|---|---|
Off-Target Effects of BCR-ABL and JAK2 Inhibitors.
Topics: Aniline Compounds; Antineoplastic Agents; Carbazoles; Dasatinib; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Furans; Fusion Proteins, bcr-abl; Gastrointestinal Stromal Tumors; Graft vs Host Disease; Harringtonines; Homoharringtonine; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Imidazoles; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mastocytosis; Myeloproliferative Disorders; Nitriles; Polycythemia Vera; Primary Myelofibrosis; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrazoles; Pyridazines; Pyrimidines; Quinolines; Scleroderma, Systemic; Smallpox; Thrombocythemia, Essential; Tuberculosis, Multidrug-Resistant | 2016 |
Oxaliplatin-induced lung toxicity. Case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Fluorouracil; Humans; Imatinib Mesylate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Stomach Neoplasms | 2012 |
[Expectation of new treatments for idiopathic interstitial pneumonias].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Clinical Trials as Topic; Hermanski-Pudlak Syndrome; Humans; Imatinib Mesylate; Interferon-gamma; Lung; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Survival Analysis | 2005 |
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Pulmonary fibrosis--a therapeutic dilemma?].
Topics: Acetylcysteine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Benzamides; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors | 2006 |
1 trial(s) available for imatinib mesylate and Pulmonary Fibrosis
| Article | Year |
|---|---|
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.
Topics: Adolescent; Adult; Aged; Benzamides; Biopsy; Dermatologic Agents; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Pyrimidines; Radiography; Scleroderma, Diffuse; Severity of Illness Index; Skin; Treatment Outcome; Ultrasonography; Vital Capacity; Young Adult | 2011 |
20 other study(ies) available for imatinib mesylate and Pulmonary Fibrosis
| Article | Year |
|---|---|
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Proliferation; Disease Models, Animal; Drug Liberation; Fibroblasts; Gold; Humans; Imatinib Mesylate; Lung; Macrophages, Alveolar; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Scleroderma, Systemic | 2019 |
Abrogation of transforming growth factor-β-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib).
Topics: Aniline Compounds; Animals; Hydroxyproline; Imatinib Mesylate; Lung; Mice; Mice, Transgenic; Nitriles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-abl; Pulmonary Fibrosis; Quinolines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic; Signal Transduction; Skin; src-Family Kinases; Transforming Growth Factor beta1 | 2018 |
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.
Topics: Animals; Benzamides; Bleomycin; Cell Line; Drug Interactions; Epidermal Growth Factor; ErbB Receptors; Feedback, Physiological; Imatinib Mesylate; Lapatinib; Lung; Mice; Myofibroblasts; Paracrine Communication; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pyrimidines; Quinazolines; Receptor, ErbB-2; Receptors, Platelet-Derived Growth Factor; Transforming Growth Factor beta; Up-Regulation | 2013 |
Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.
Topics: Animals; Benzamides; Case-Control Studies; Chemotaxis; Drug Evaluation, Preclinical; Female; Humans; Imatinib Mesylate; Injections, Intraperitoneal; Mice, Inbred C57BL; Piperazines; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Receptors, CXCR4; Signal Transduction | 2014 |
Imatinib for sclerodermatous graft-versus-host disease in lung transplantation.
Topics: Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Lung Transplantation; Protein Kinase Inhibitors; Pulmonary Fibrosis; Young Adult | 2015 |
Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis.
Topics: Adult; Biomarkers; Case-Control Studies; Cell Line; Cells, Cultured; Chemotaxis; Cluster Analysis; Extracellular Matrix; Female; Gene Expression Profiling; Hermanski-Pudlak Syndrome; Humans; Imatinib Mesylate; Immunophenotyping; Lung; Male; Mast Cells; Membrane Proteins; Middle Aged; Mutation; Phenotype; Pulmonary Alveoli; Pulmonary Fibrosis; Young Adult | 2016 |
Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.
Topics: Benzamides; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Imatinib Mesylate; Middle Aged; Mixed Connective Tissue Disease; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome | 2008 |
Imatinib as a novel therapeutic approach for fibrotic disorders.
Topics: Benzamides; Drug Evaluation, Preclinical; Fibrosis; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome | 2009 |
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?
Topics: Animals; Benzamides; Clinical Trials as Topic; Dasatinib; Disease Models, Animal; Drugs, Investigational; ErbB Receptors; Fibrosis; Graft vs Host Disease; Humans; Imatinib Mesylate; Mixed Connective Tissue Disease; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pulmonary Fibrosis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Scleroderma, Systemic; Thiazoles | 2010 |
Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
Topics: Acute Lung Injury; Animals; Antibiotics, Antineoplastic; Benzamides; Biomarkers, Tumor; Bleomycin; Blotting, Western; Gene Expression Regulation; Imatinib Mesylate; Interleukin-1beta; Interleukin-6; Male; Mice; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Fibrosis; Pyrimidines; Real-Time Polymerase Chain Reaction; Time Factors; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2011 |
Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pulmonary Alveoli; Pulmonary Eosinophilia; Pulmonary Fibrosis; Pyrimidines | 2004 |
Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Topics: Animals; Benzamides; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Fibroblasts; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Piperazines; Pulmonary Fibrosis; Pyrimidines; Reference Values; Treatment Outcome | 2005 |
Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.
Topics: Animals; Benzamides; Biomarkers; Bleomycin; Drug Therapy, Combination; Follow-Up Studies; Gene Expression; Glucocorticoids; Imatinib Mesylate; Lung; Male; Piperazines; Pneumonia; Prednisolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Fibrosis; Pyrimidines; Rats; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2006 |
Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis.
Topics: Aged; Antineoplastic Agents; Benzamides; Comorbidity; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lung Diseases, Interstitial; Male; Piperazines; Pulmonary Fibrosis; Pyrimidines; Tomography, X-Ray Computed | 2008 |
Treatment of pulmonary fibrosis in systemic sclerosis: light at the end of the tunnel?
Topics: Animals; Benzamides; Disease Models, Animal; Fibrosis; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Scleroderma, Systemic | 2007 |
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Topics: Aged; Animals; Benzamides; Bleomycin; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Female; Fibroblasts; Fibrosis; Gene Expression; Humans; Imatinib Mesylate; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C3H; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; RNA, Messenger; Scleroderma, Systemic; Skin; Specific Pathogen-Free Organisms | 2007 |
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
Topics: Animals; Antineoplastic Agents; Benzamides; Bleomycin; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Gene Expression; Imatinib Mesylate; Indoles; Male; Piperazines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Rats; Rats, Wistar; Signal Transduction; Vascular Endothelial Growth Factor A | 2007 |
[Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice].
Topics: Animals; Becaplermin; Benzamides; Bleomycin; Disease Models, Animal; Hydroxyproline; Imatinib Mesylate; Lung; Mice; Mice, Inbred C57BL; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pulmonary Fibrosis; Pyrimidines; Random Allocation | 2007 |
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines | 2007 |
Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Asbestos, Crocidolite; Benzamides; Cell Culture Techniques; Cell Movement; Cells, Cultured; Fibroblasts; Humans; Imatinib Mesylate; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred Strains; Piperazines; Pneumonia; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Fibrosis; Pyrimidines | 2007 |